Sovaldi is an antiviral medicine used in combination with other medicines to treat adults and children from 3 years of age with chronic (long-term) hepatitis C, an infection caused by the hepatitis C virus that affects the liver. Sovaldi contains the active substance sofosbuvir.
Therapeutic Indication
### Therapeutic indication Sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adult and paediatric patients aged 3 years and above (see sections 4.2, 4.4 and 5.1). For hepatitis C virus (HCV) genotype specific activity, see sections 4.4 and 5.1. Sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adults and paediatric patients aged 3 years and above (see sections 4.2, 4.4 and 5.1). For hepatitis C virus (HCV) genotype specific activity, see sections 4.4 and 5.1.
Therapeutic Area (MeSH)
ATC Code
J05AX15
ATC Item
xj 05 ax 15
Pharmacotherapeutic Group
Antivirals for systemic use
Active Substance (Summary)
INN / Common Names
EMA Name
Sovaldi
Medicine Name
Sovaldi
Aliases
N/A
